UnitedHealth Group Stock Holds Below Record Highs Despite Strong Earnings

UnitedHealth Group Inc. (US91324P1021) is trading below its recent peak despite strong second quarter earnings and reaffirmed fiscal 2026 guidance that signal ongoing profit growth as of late August 2026.

The company's stock has been oscillating within a relatively narrow band, with prices around $389 to $391, which still sit more than $70 below the one-year high of $461.62 but remain roughly $130 above the one-year low of $255.96.

UnitedHealth Group generated earnings per share of $6.38 in the second quarter of 2026, surpassing a consensus estimate of $4.94 and delivering a positive $1.44 variance versus expectations. The company also reported second-quarter revenue of $112.03 billion, above analyst expectations.

The forward price to earnings ratio of 17.96 based on 2026 earnings estimates suggests that investors assign a premium valuation to UnitedHealth Group relative to broader health insurance and managed care peers, reflecting expectations of solid growth and strong execution.